DEALS: Corgentech, AlgoRx to merge pipelines

DEALS

WHO

WITH

WHAT

SCOOP

Corgentech

AlgoRx Pharmaceuticals

Merger/stock swap

The combined company will have four products in its pipeline, including AlgoRx's portfolio of pain management drug candidates.

Celtic Pharma

Neurobological Technologies

Drug acquisition

Celtic gains control of Xerecept, in Phase III for swelling associated with brain tumors.

Clinical Data

Icoria

$12.5 million acquisition

The buyout is being billed as a combination of Icoria's biomarker discovery platform with Clinical Data's molecular diagnostics business model.

Qiagen

Shenzhen PG Biotech

Acquisition

The acquisition will expand Qiagen's position as a provider of molecular diagnostics solutions to OEM partners and customers in Asia.

Pharmagene

Asterand

Stock swap merger

The combination will create an expanded approach to human tissue supply and human tissue based research services.

Daiichi Pharmaceutical

Daiichi Suntory Pharma

Acquisition

The deal gives Daiichi control of a joint venture it created with Suntory as it works to beef up its financial strength.

Esprit Pharma

Metagen Pharmaceuticals

Acquisition

Esprit gains control of PROSED(R) EC, a urinary analgesic/ antispasmodic/antiseptic.